CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

29 hedge funds and large institutions have $2.25M invested in CASI Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WSCM
1
Wellington Shields Capital Management
New York
$595K
2
RJFSA
2
Raymond James Financial Services Advisors
Florida
$58K
3
MHP
3
Manatuck Hill Partners
Connecticut
$16K
4
MC
4
Moors & Cabot
Massachusetts
$83K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$46K

Top Sellers

1
VKH
1
Virtu KCG Holdings
New York
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$18K
4
BFA
4
BlackRock Fund Advisors
California
$38K
5
TRCT
5
Tower Research Capital (TRC)
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AIG
26
American International Group
New York
$0 130 – –
Creative Planning
27
Creative Planning
Kansas
$0 9 – –
CPIG
28
Chicago Partners Investment Group
Illinois
$0 27 – –
FWM
29
Focused Wealth Management
New York
$0 45 – –
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$0 90 – –
NFG
31
Next Financial Group
Texas
$0 2 – –
Wells Fargo
32
Wells Fargo
California
$0 80 +18 +29%
Morgan Stanley
33
Morgan Stanley
New York
$0 348 +19 +6%
1
2